AI assistant
Sending…
ASSEMBLY BIOSCIENCES, INC. — Director's Dealing 2010
Dec 22, 2010
33081_dirs_2010-12-22_057858cd-bd04-433d-9f75-7c067059904b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VENTRUS BIOSCIENCES INC (VTUS)
CIK: 0001426800
Period of Report: 2010-12-22
Reporting Person: ELLISON RUSSELL H (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-12-22 | Stock Options (right to buy) | $6 | A | 573599 | Acquired | 2020-12-22 | Common Stock (573599) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants (right to buy) | $7.69 | 2014-11-08 | Common Stock (8065) | 8065 | Direct |
Footnotes
F1: One-third vested on 12/22/2010 and the remainder vests in equal installments on the first and second anniversary after 12/22/2010.
F2: The warrant vested in three installments on 3/21/2008 (2,689 shares), 3/21/2009 (2,688 shares) and 3/21/2010 (2,688 shares).
More from ASSEMBLY BIOSCIENCES, INC.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
Mar 30
Regulatory Filings
2026
Mar 19
Regulatory Filings
2026
Mar 19
Major Shareholding Notification
2026
Feb 9
Regulatory Filings
2025
Dec 8
Regulatory Filings
2025
Nov 21